GNH USA

Europe — EMA

Hydroxycarbamide Medac

GNH USA supplies Hydroxycarbamide Medac (Hydroxycarbamide), a antimetabolite for chronic myelogenous leukemia, sickle cell disease, and polycythemia vera.

Hydroxycarbamide

Request sourcing

1
Pack/s

What is Hydroxycarbamide?

Hydroxycarbamide, the active ingredient in Hydroxycarbamide Medac, is an antimetabolite presented as an oral formulation for oral use. It treats chronic myelogenous leukemia, sickle cell disease, and polycythemia vera in appropriate patients.

GNH USA supplies Hydroxycarbamide Medac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.

What is Hydroxycarbamide used for?

Hydroxycarbamide is employed in hematologic malignancies and blood disorders where rapid cell proliferation is a therapeutic target.

- Chronic myelogenous leukemia: reduces proliferation of leukemic cells, helping to control disease progression. - Sickle cell disease: decreases sickled red‑cell formation and vaso‑occlusive crises. - Polycythemia vera: lowers red‑cell mass, mitigating risk of thrombosis and related complications.

What are the side effects of Hydroxycarbamide?

Hydroxycarbamide may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Abdominal pain - Skin rash - Fatigue

Serious or Rare Side Effects: - Bone‑marrow suppression (e.g., neutropenia, thrombocytopenia) - Severe infections - Hepatic toxicity - Renal impairment - Hypersensitivity reactions - Secondary malignancies

What precautions apply to Hydroxycarbamide?

Use of Hydroxycarbamide requires careful monitoring and patient counseling.

- Blood counts: monitor complete blood count regularly to detect marrow suppression. - Liver function: assess hepatic enzymes before and during therapy. - Renal function: adjust dosing in patients with impaired renal clearance. - Pregnancy: avoid use unless benefits outweigh potential risks; data are limited. - Infection risk: postpone treatment in the presence of active severe infections. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

What does Hydroxycarbamide interact with?

Hydroxycarbamide can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Allopurinol: increased risk of severe bone‑marrow toxicity. - Azathioprine: additive myelosuppression. - Methotrexate: heightened hematologic toxicity. - Protease inhibitor antiretrovirals: altered drug metabolism.

Moderate Interactions (Monitor Closely): - NSAIDs: may exacerbate gastrointestinal irritation. - Penicillins: potential additive marrow suppression. - Warfarin: possible changes in INR requiring closer monitoring.

Frequently asked questions

What is Hydroxycarbamide Medac used for?+
Hydroxycarbamide Medac is prescribed for the management of chronic myelogenous leukemia, sickle cell disease, and polycythemia vera. In each condition the drug works to limit the growth of abnormal blood cells, thereby reducing disease‑related complications and improving clinical outcomes.
How does hydroxycarbamide work?+
Hydroxycarbamide blocks the enzyme ribonucleotide reductase, which is essential for converting ribonucleotides into deoxyribonucleotides. By limiting the supply of DNA building blocks, the drug slows DNA synthesis and curtails the proliferation of rapidly dividing cells, such as malignant or sickled red blood cells.
What is the usual dose of Hydroxycarbamide Medac?+
The dose of Hydroxycarbamide Medac is individualized by the prescribing clinician based on the specific indication, patient weight, renal and hepatic function, and response to therapy. Dosage adjustments are made according to laboratory monitoring and clinical judgment.
Is Hydroxycarbamide safe in pregnancy or breastfeeding?+
Hydroxycarbamide is classified with an unknown pregnancy category, and limited data exist on its safety during lactation. It should only be used when the potential benefit justifies the possible risk to the fetus or infant, and treatment decisions should involve a specialist in maternal‑fetal medicine.
How do I order Hydroxycarbamide Medac from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Hydroxycarbamide compare with other antimetabolites?+
Hydroxycarbamide belongs to the antimetabolite class and is distinct from agents such as methotrexate or cytarabine, which target different enzymes. Compared with methotrexate, hydroxycarbamide has a more specific effect on ribonucleotide reductase and is often preferred for chronic myelogenous leukemia and sickle cell disease due to its oral administration and established efficacy profile.
What are the storage and handling requirements for Hydroxycarbamide Medac?+
Hydroxycarbamide Medac should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity.
How is Hydroxycarbamide Medac administered?+
Hydroxycarbamide Medac is taken orally, usually as a tablet. It can be swallowed with water, with or without food, unless the prescribing physician advises otherwise. Patients should follow the exact dosing schedule provided by their healthcare professional.
What are the most serious risks associated with Hydroxycarbamide?+
The most serious adverse effects include bone‑marrow suppression leading to neutropenia or thrombocytopenia, severe infections, hepatic toxicity, renal impairment, and rare hypersensitivity reactions. Regular laboratory monitoring is essential to detect these complications early and adjust therapy as needed.
Who should not use Hydroxycarbamide Medac?+
Hydroxycarbamide Medac is contraindicated in patients with known hypersensitivity to hydroxycarbamide or any of its excipients, those with severe bone‑marrow failure, and individuals with active, uncontrolled infections. Caution is also advised for pregnant or breastfeeding women, and the drug should be avoided unless the therapeutic benefit outweighs potential risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Hydroxycarbamide
Route
Oral Use
Manufacturer
Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
Origin
EU

Related products

Hidroxicarbamida Generis

Hidroxicarbamida Generis

Hydroxycarbamide

Eugia Pharma (Malta) Ltd
EU
Hidroxicarbamida Hikma

Hidroxicarbamida Hikma

Hydroxycarbamide

Hikma Farmacêutica (Portugal), S.A.
EU
Hidroxicarbamida Hikma

Hidroxicarbamida Hikma

Hydroxycarbamide

Hikma Farmacêutica (Portugal), S.A.
EU
Hidroxicarbamida Hikma

Hidroxicarbamida Hikma

Hydroxycarbamide

Hikma Farmacêutica (Portugal), S.A.
EU